During the past decade, Cleveland Clinic Cancer Center Independence conducted 47 clinical trials. In the 10-year time frame, 47 clinical trials started and 43 clinical trials were completed, i.e. on average, 91.5% percent of trials that started reached the finish line to date. In the past 5 years, 8 clinical trials started and 32 clinical trials were completed. i.e. 400% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Independence" #1 sponsor was "National Cancer Institute (NCI)" with 39 trials, followed by "SWOG Cancer Research Network" with 18 trials sponsored, "NRG Oncology" with 9 trials sponsored, "Alliance for Clinical Trials in Oncology" with 5 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 5 trials sponsored. Other sponsors include 4 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cleveland Clinic Cancer Center Independence" #1 collaborator was "National Cancer Institute (NCI)" with 45 trials as a collaborator, "NRG Oncology" with 15 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Radiation Therapy Oncology Group" with 3 trials as a collaborator. Other collaborators include 11 different institutions and companies that were collaborators in the rest 18 trials.

According to Clinical.Site data, the most researched conditions in "Cleveland Clinic Cancer Center Independence" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (6 trials), "Stage IIIA Lung Non-Small Cell Cancer AJCC v7" (5 trials) and "Stage IV Breast Cancer AJCC v6 and v7" (5 trials). Many other conditions were trialed in "Cleveland Clinic Cancer Center Independence" in a lesser frequency.

Most popular intervention types in "Cleveland Clinic Cancer Center Independence" are "Drug" (69 trials), "Other" (56 trials), "Biological" (29 trials), "Radiation" (27 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (40 trials), "Quality-of-Life Assessment" (19 trials), "Cisplatin" (12 trials), "Carboplatin" (11 trials) and "Paclitaxel" (11 trials). Other intervention names were less common.

The vast majority of trials in "Cleveland Clinic Cancer Center Independence" are 70 trials for "All" genders, 9 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Cleveland Clinic Cancer Center Independence". undefined are not yet recruiting, 16 are recruiting, 42 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 21 completed trials in Cleveland Clinic Cancer Center Independence, 1 suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Cleveland Clinic Cancer Center Independence, 2 "Phase 1" clinical trials were conducted, 33 "Phase 2" clinical trials and 58 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".